Abstract:Symptoms of the disorders across the irritable bowel syndrome (IBS) spectrum include several different, usually postprandial, abdominal complaints. Up to date, dietary treatments of the IBS have neither been personalized nor diagnosed with sufficient scientific evidence. They have mostly been treated using 'one-size-fits-all' approaches. Such include exclusion diets, a low fermentable oligosaccharides, disaccharides, monosaccharides and polyols diet, and gluten-free diets, lactose-free diets, a diet recommended by the UK National Institute for Health and Care Excellence, and a wheat-free diet. The exact pathophysiology of IBS disorders across the spectrum is still unclear. However, the symptom profile of IBS spectrum disorders seems similar to that of food intolerance/malabsorption syndromes. Celiac disease, fructose malabsorption, histamine intolerance and lactose intolerance represent food intolerance/malabsorption disorders based on the indigestion of sugars and/or proteins. Helicobacter pylori infection may potentially promote the development of IBS and, when facing a case of IBS-like symptoms, a search for intolerance/malabsorption and H. pylori should be added to find the correct treatment for the respective patient. This review will discuss why the 'one-size-fits-all' dietary approach in the treatment of complaints across the IBS spectrum cannot be successful. Hence, it will provide an overview of the most common overall dietary approaches currently used, and why those should be discouraged. Alternatively, a noninvasive diagnostic workup of the pathophysiologic factors of food intolerance/malabsorption in each patient with symptoms of the IBS spectrum is suggested. Additionally, if H. pylori is found, eradication therapy is mandatory, and if food intolerance/malabsorption is detected, an individual and personalized dietary intervention by a registered dietician is recommended.

The Irritable Bowel Syndrome: Mechanisms and a Practical Approach to Management

Irritable bowel syndrome: treatment based on pathophysiology and biomarkers

Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches

Diagnostic and therapeutic strategies in the irritable bowel syndrome

Irritable bowel syndrome: diagnosis and management

Irritable Bowel Syndrome: A Review and Update

Irritable bowel syndrome - from etiopathogenesis to therapy

Irritable Bowel Syndrome: Treating the Gut and Brain/Mind at the Same Time

Irritable bowel syndrome: recent and novel therapeutic approaches

A personalized management approach in disorders of the irritable bowel syndrome spectrum

Irritable bowel syndrome.

[The proven and the new in the pharmacotherapy of irritable bowel syndrome]

Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview

Current and novel therapeutic options for irritable bowel syndrome management

The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy

Pharmacological management of irritable bowel syndrome

New developments in the treatment of irritable bowel syndrome

Psychotherapeutic Interventions in Irritable Bowel Syndrome

Current state of the non‐pharmacological management of irritable bowel syndrome: an up‐to‐date review of the literature

Review Article: Current and future treatment approaches for IBS with diarrhoea (IBS-D) and IBS mixed pattern (IBS-M)

New drugs in the management of the irritable bowel syndrome